APOE ε 2 allele is an independent risk factor for vulnerable carotid plaque in ischemic stroke patients

Neurological Research

Volumn 36, Issue 11, 2014, Pages 950-954

  Blazejewska Hyzorek, Beata ^a   Gromadzka, Grazyna ^a,b   Skowronska, Marta ^a   Czlonkowska, Anna ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Apolipoproteins; Carotid plaque; Ischemic stroke

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; APOLIPOPROTEIN E2;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; COMMON CAROTID ARTERY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; ALLELE; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

AGED; ALLELES; APOLIPOPROTEIN E2; BRAIN ISCHEMIA; CAROTID STENOSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; RISK FACTORS; STROKE;

EID: 84918819962     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132814Y.0000000385     Document Type: Article

References (27)

1. Paternoster L, Gonzalez NAM, Lewis S, Sudlow C. Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke. Stroke. 2008;39:48-54.
2. Sudlow C, Gonzalez NAM, Kim J, Clark C. Does Apolipoprotein E Genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls. Stroke. 2006;37:364-70.
3. Granér M, Kahri J, Varpula M, Salonen RM, Nyyssönen K, Jauhiainen M, et al. Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease.Nutr Metab CardiovascDis. 2008;18:271-7.
4. Kwee RM, van Oostenbrugge RJ, Hofstra L, Teule GJ, van Engelshoven JM, Mess WH, et al. Identifying vulnerable carotid plaques by noninvasive imaging. Neurology. 2008;70:2401-9.
5. Chutinet A, Suwanwela NC, Snabboon T, Chaisinanunkul N, Furie KL, Phanthumchinda K. Association between genetic polymorphisms and sites of cervicocerebral artery atherosclerosis. J Stroke Cerebrovasc Dis. 2012;21(5):379-85.
6. Slooter AJ, Bots ML, Havekes LM, del Sol AI, Cruts M, Grobbee DE, et al. Apolipoprotein E and carotid atherosclerosis: the Rotterdam study. Stroke. 2001;32:1947-52.
7. Beilby JP, Hunt CC, Palmer LJ, Chapman CM, Burley JP, McQuillan BM, et al. Carotid Ultrasound Disease Assessment Study. Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Stroke. 2003;34:869-74.
8. Karvonen J, Kauma H, Kervinen K, Ukkola O, Rantala M, Päivänsalo M, et al. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens. 2002;20:2371-8.
9. Asakimori Y, Yorioka N, Tanaka J, Kohno N. Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients. Am J Kidney Dis. 2003;41:822-32.
10. Debette S, Lambert JC, Gariépy J, Fievet N, Tzourio C, Dartigues JF, et al. New insight into the association of apolipoprotein E genetic variants with carotid plaques and intima-media thickness. Stroke. 2006;37:2917-23.
11. Kumar NT, Liestøl K, Løberg EM, Reims HM, Brorson SH, Maehlen J. The apolipoprotein E polymorphism and cardiovascular diseases-an autopsy study. Cardiovasc Pathol. 2012;21(6):461-9.
12. World Health Organization (WHO). International classification of impairments disabilities, and handicaps. Geneva: World Health Organization; 1980.
13. Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285, 2486-2497.
14. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-8.
15. Zureik M, Ducimetière P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol. 2000;20:1622-9.
16. De Bray JM, Baud JM, Dauzat M. Consensus concerning the morphology and the risk of carotid plaques. Cerebrovasc Dis. 1997;8:289-96.
17. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque. A multifocal disease. Circulation. 2003; 107:2072-5.
18. Mathiesen EB, Bonaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromso Study. Circulation. 2001; 103:2171-5.
19. Prabhakaran S, Rundek T, Ramas R, Elkind MS, Paik MC, Boden-Albala B, et al. Carotid plaque surface irregularity predicts ischemic stroke: the Northern Manhattan study. Stroke. 2006;37:2696-701.
20. Fisher M, Paganini-Hill A, Martin A, Cosgrove M, Toole JF, Barnett HJ, et al. Carotid plaque pathology. Thrombosis, ulceration, and stroke pathogenesis. Stroke. 2005;36:253-7.
21. Utermann G, Vogelberg KH, Steinmetz A, Schoenborn W, Pruin N, Jaeschke M, et al. Polymorphism of apolipoprotein E, II: genetics of hyperlipoproteinemia type III. Clin Genet. 1979;15:37-62.
22. Grocott HP, Newman MF, El-Moalem H, Bainbridge D, Butler A, Laskowitz DT. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001;122:622-3.
23. Stannard AK, Riddell DR, Sacre SM, Tagalakis AD, Langer C, von Eckardstein A, et al. Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Biol Chem. 2001;276:46011-6.
24. Mazzone T. Apolipoprotein E secretion by macrophages: its potential physiological functions. Curr Opin Lipidol. 1996;7:303-7.
25. Davignon J. Apolipoprotein E and atherosclerosis: beyond lipid effect. Arterioscler Thromb Vasc Biol. 2005;25:267-9.
26. Calara F, Silvestre M, Casanada F, Yuan N, Napoli C, Palinski W. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol. 2001;195:257-63.
27. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford Plaque Study. Circulation. 2006;113:2320-8.